EZH2 and prostate cancer: Dysregulation of EZH2 was first linked to cancer by performing gene expression profiling in prostate cancer, which showed EZH2 is involved in prostate cancer progression, and its expression distinguishes indolent forms of prostate cancer from those forms at risk of lethal progression8.